Autoimmunity to Vimentin Is Associated with Outcomes of Patients with Idiopathic Pulmonary Fibrosis

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Immunology

• Publication date

  2017-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.4049/jimmunol.1700473PMID 28754682PMCID PMC5563167
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immune Inflammation and Disease Progression in Idiopathic Pulmonary Fibrosis

  2016cited by this paper
• Downregulation of vimentin in macrophages infected with live Mycobacterium tuberculosis is mediated by Reactive Oxygen Species

  2016cited by this paper
• Correction: Autoantibody-Targeted Treatments for Acute Exacerbations of Idiopathic Pulmonary Fibrosis

  2015cited by this paper
• Autoantibody-Targeted Treatments for Acute Exacerbations of Idiopathic Pulmonary Fibrosis

  2015cited by this paper
• New insights into immune mechanisms underlying autoimmune diseases of the gastrointestinal tract.

  2015cited by this paper
• Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features

  2015cited by this paper
• Oral mucosal manifestations of autoimmune skin diseases.

  2015cited by this paper
• Thyroid dysfunction: an autoimmune aspect.

  2015cited by this paper
• Pathogenesis of idiopathic pulmonary fibrosis.

  2014cited by this paper
• C-X-C motif chemokine 13 (CXCL13) is a prognostic biomarker of idiopathic pulmonary fibrosis.

  2014cited by this paper
• Peripheral Blood Mononuclear Cell Gene Expression Profiles Predict Poor Outcome in Idiopathic Pulmonary Fibrosis

  2013cited by this paper
• Patients with idiopathic pulmonary fibrosis with antibodies to heat shock protein 70 have poor prognoses.

  2013cited by this paper
• Plasma B Lymphocyte Stimulator and B Cell Differentiation in Idiopathic Pulmonary Fibrosis Patients

  2013cited by this paper
• Role of anti-vimentin antibodies in allograft rejection

  2013cited by this paper
• Multiple associations between a broad spectrum of autoimmune diseases, chronic inflammatory diseases and cancer.

  2012cited by this paper
• Endothelial-mesenchymal transition and its contribution to the emergence of stem cell phenotype.

  2012cited by this paper
• Identification of periplakin as a new target for autoreactivity in idiopathic pulmonary fibrosis.

  2011cited by this paper
• American Thoracic Society Documents An Official ATS / ERS / JRS / ALAT Statement : Idiopathic Pulmonary Fibrosis : Evidence-based Guidelines for Diagnosis and Management

  2011cited by this paper
• Visual Effects of Haptic Feedback Are Large but Local

  2011cited by this paper
• Requirement of Podocalyxin in TGF-Beta Induced Epithelial Mesenchymal Transition

  2011cited by this paper
• Identification of Three New Autoantibodies Associated with Systemic Lupus Erythematosus Using Two Proteomic Approaches

  2011cited by this paper
• The HLA Class II Allele DRB1*1501 Is Over-Represented in Patients with Idiopathic Pulmonary Fibrosis

  2011cited by this paper
• The pathogenesis of idiopathic pulmonary fibrosis

  2010influential reference
• Expression level of a pancreatic neo-antigen in beta cells determines degree of diabetes pathogenesis.

  2010cited by this paper
• CD28 Down-Regulation on Circulating CD4 T-Cells Is Associated with Poor Prognoses of Patients with Idiopathic Pulmonary Fibrosis

  2010cited by this paper
• Mechanisms of Immune Complex–Mediated Neutrophil Recruitment and Tissue Injury

  2009cited by this paper
• Infections and Autoimmunity: A Panorama

  2008cited by this paper
• Identification of Annexin 1 as a Novel Autoantigen in Acute Exacerbation of Idiopathic Pulmonary Fibrosis1

  2008cited by this paper
• Vimentin autoantibodies induce platelet activation and formation of platelet‐leukocyte conjugates via platelet‐activating factor

  2008cited by this paper
• Cellular and Humoral Autoreactivity in Idiopathic Pulmonary Fibrosis1

  2007cited by this paper
• B cells move to centre stage: novel opportunities for autoimmune disease treatment

  2006cited by this paper
• Inflammatory Cell Phenotyping of the Pulmonary Interstitium in Idiopathic Interstitial Pneumonia

  2006cited by this paper
• Lymphoid neogenesis in chronic inflammatory diseases

  2006cited by this paper
• Vimentin function in lymphocyte adhesion and transcellular migration

  2006cited by this paper
• Cutting Edge: Nonproliferating Mature Immune Cells Form a Novel Type of Organized Lymphoid Structure in Idiopathic Pulmonary Fibrosis1

  2006cited by this paper
• Idiopathic pulmonary fibrosis related to endothelial injury and antiendothelial cell antibodies.

  2006cited by this paper
• Coming together: the ATS/ERS consensus on clinical pulmonary function testing

  2005cited by this paper
• Molecular Mimicry, Microbial Infection, and Autoimmune Disease: Evolution of the Concept

  2005cited by this paper
• T-cell-mediated signalling in immune, inflammatory and angiogenic processes: the cascade of events leading to inflammatory diseases.

  2004cited by this paper
• Antibodies in scleroderma: Direct pathogenicity and phenotypic associations

  2004cited by this paper
• The Endothelial Cell-Specific Antibody PAL-E Identifies a Secreted Form of Vimentin in the Blood Vasculature

  2004cited by this paper
• High antigen dose and activated dendritic cells enable Th cells to escape regulatory T cell‐mediated suppression in vitro

  2003cited by this paper
• Vimentin is secreted by activated macrophages

  2003cited by this paper
• Epitope spreading in immune-mediated diseases: implications for immunotherapy

  2002cited by this paper
• Detection of antivimentin antibody in sera of patients with idiopathic pulmonary fibrosis and non‐specific interstitial pneumonia

  2002cited by this paper
• Evidence-based guidelines for the use of immunologic tests: antinuclear antibody testing.

  2002cited by this paper
• Efficient Priming of CD4+ and CD8+ T Cells by DNA Vaccination Depends on Appropriate Targeting of Sufficient Levels of Immunologically Relevant Antigen to Appropriate Processing Pathways1

  2002cited by this paper
• Impairment of bleomycin-induced lung fibrosis in CD28-deficient mice

  2001cited by this paper
• Impairment of Bleomycin-Induced Lung Fibrosis in CD28-Deficient Mice1

  2001cited by this paper
• Autoantibodies to IL-1α in sera from rapidly progressive idiopathic pulmonary fibrosis

  2001cited by this paper
• Autoantibodies to IL-1 alpha in sera from rapidly progressive idiopathic pulmonary fibrosis.

  2001influential reference
• CD8 T cell ignorance or tolerance to islet antigens depends on antigen dose.

  1999cited by this paper
• Transient arrest of 3T3 cells in mitosis and inhibition of nuclear lamin reassembly around chromatin induced by anti-vimentin antibodies.

  1993cited by this paper

• Emerging Molecular Targets and Natural Therapeutics for Idiopathic Pulmonary Fibrosis: Insights into Mechanisms, Risks, and COVID-19 Links.

  2025cites this paper
• Active Antigen-Specific Adaptive Immune Responses Are Shared among Patients with Progressive Fibrotic Interstitial Lung Disease.

  2025cites this paper
• Machine learning-based integration identifies plasma cells-related gene signature ST6GAL1 in idiopathic pulmonary fibrosis

  2025cites this paper
• Structure and function of vimentin in the generation and secretion of extracellular vimentin in response to inflammation

  2025cites this paper
• Anti-Heat Shock Protein 70 Autoantibodies from Patients with Idiopathic Pulmonary Fibrosis Epigenetically Enhance Lung Fibroblast Apoptosis Resistance and Bcl-2 Expression.

  2024cites this paper
• Design of the STRIVE-IPF Trial- Study of Therapeutic Plasma Exchange, Rituximab, and Intravenous Immunoglobulin for Acute Exacerbations of Idiopathic Pulmonary Fibrosis

  2024cites this paper
• Les anticorps anti-muscle lisse sont fréquents dans la FPI mais ne sont pas associés au pronostic

  2024cites this paper
• Design of the STRIVE-IPF trial- study of therapeutic plasma exchange, rituximab, and intravenous immunoglobulin for acute exacerbations of idiopathic pulmonary fibrosis

  2024cites this paper
• Atractylodinol prevents pulmonary fibrosis through inhibiting TGF-β receptor 1 recycling by stabilizing vimentin.

  2023cites this paper
• MiR-30a inhibits silica dust-induced epithelial-mesenchymal transition by targeting Snail.

  2023cites this paper
• A novel take on idiopathic pulmonary fibrosis disease progression: localised autoimmunity

  2023cites this paper
• Hotspots and Frontiers of Host Immune Response in Idiopathic Pulmonary Fibrosis: A Bibliometric and Scientific Visual Research from 2000 to 2022

  2023cites this paper
• Antifibrotic mechanism of avitinib in bleomycin-induced pulmonary fibrosis in mice

  2023cites this paper
• Anti-vimentin antibodies are associated with higher severity of Sjögren's disease.

  2023cites this paper
• The diverse actions of cytoskeletal vimentin in bacterial infection and host defense.

  2023cites this paper
• Anti-mutated citrullinated vimentin antibodies are increased in IPF patients.

  2023cites this paper
• Advanced lung organoids and lung-on-a-chip for cancer research and drug evaluation: a review

  2023cites this paper
• Mass spectrometry-based autoimmune profiling reveals predictive autoantigens in idiopathic pulmonary fibrosis

  2023cites this paper
• Vimentin takes a hike - Emerging roles of extracellular vimentin in cancer and wound healing.

  2023cites this paper
• Vimentin at the core of wound healing.

  2023cites this paper
• Extracellular vimentin as a versatile immune suppressive protein in cancer.

  2023cites this paper
• Proteomic Network Analysis of Bronchoalveolar Lavage Fluid in Ex-Smokers to Discover Implicated Protein Targets and Novel Drug Treatments for Chronic Obstructive Pulmonary Disease

  2022cites this paper
• Role of Immune Cells in the Initiation and Progression of Pulmonary Fibrosis.

  2022cites this paper
• Anti-Sitoplazmik ve Anti-Mitotik Otoantikorlar; Bu Antikorların Hastalıklarla İlişkisi Var Mı?

  2022cites this paper
• Pathophysiological Role of Vimentin Intermediate Filaments in Lung Diseases

  2022cites this paper
• An Autoantigen Atlas From Human Lung HFL1 Cells Offers Clues to Neurological and Diverse Autoimmune Manifestations of COVID-19

  2022cites this paper
• Impact of Vimentin on Regulation of Cell Signaling and Matrix Remodeling

  2022cites this paper
• A master autoantigen-ome links alternative splicing, female predilection, and COVID-19 to autoimmune diseases

  2022cites this paper
• Are sputum autoantibodies more clinically relevant in idiopathic pulmonary fibrosis than serum autoantibodies?

  2022cites this paper
• Airway-specific autoantibodies identify a subset of patients with fibrotic interstitial lung disease

  2021cites this paper
• An Autoantigen Atlas from Human Lung HFL1 Cells Offers Clues to Neurological and Diverse Autoimmune Manifestations of COVID-19

  2021cites this paper
• A proteomics workflow reveals predictive autoantigens in idiopathic pulmonary fibrosis

  2021cites this paper
• An Autoantigen Profile of Human A549 Lung Cells Reveals Viral and Host Etiologic Molecular Attributes of Autoimmunity in COVID-19

  2021cites this paper
• Citrullinated vimentin mediates development and progression of lung fibrosis

  2021cites this paper
• Changes in Neutrophil–Lymphocyte or Platelet–Lymphocyte Ratios and Their Associations with Clinical Outcomes in Idiopathic Pulmonary Fibrosis

  2021cites this paper
• An autoantigen profile of human A549 lung cells reveals viral and host etiologic molecular attributes of autoimmunity in COVID-19

  2021cites this paper
• SSc biomarkers detection in the secretome of TGFβ1-activated primary human lung fibroblasts.

  2021cites this paper
• Immune cells in lens injury repair and fibrosis.

  2021cites this paper
• A Master Autoantigen-ome Links Alternative Splicing, Female Predilection, and COVID-19 to Autoimmune Diseases

  2021cites this paper
• Set Up for Failure: Pre-Existing Autoantibodies in Lung Transplant

  2021cites this paper
• Post-mortem assessment of vimentin expression as a biomarker for renal tubular regeneration following acute kidney injury

  2021cites this paper
• MicroSPECT Imaging-Guided Treatment of Idiopathic Pulmonary Fibrosis in Mice with a Vimentin-Targeting 99mTc-Labeled N-Acetylglucosamine-Polyethyleneimine.

  2021cites this paper
• A novel prognostic signature for idiopathic pulmonary fibrosis based on five-immune-related genes

  2021cites this paper
• Biomarkers in Idiopathic Pulmonary Fibrosis

  2021cites this paper
• ROCK2 inhibition attenuates profibrogenic immune cell function to reverse thioacetamide-induced liver fibrosis

  2021cites this paper
• Autoantibodies are present in the bronchoalveolar lavage but not circulation in patients with fibrotic interstitial lung disease

  2021cites this paper
• Correlates of survival after autoantibody reduction therapy for acute IPF exacerbations

  2021cites this paper
• Rosette-forming Epithelioid Osteosarcoma

  2021cites this paper
• Shedding light on developmental drugs for idiopathic pulmonary fibrosis

  2020cites this paper
• A proteomic repertoire of autoantigens identified from the classic autoantibody clinical test substrate HEp-2 cells

  2020cites this paper
• Evolutionary relationship based on nucleotide sequence variations in vimentin and CD4 genes among indigenous and commercial poultry species

  2020cites this paper
• The association between white blood cell count and outcomes in patients with idiopathic pulmonary fibrosis.

  2020cites this paper
• Ablation of miR-144 increases vimentin expression and atherosclerotic plaque formation

  2020cites this paper
• Exacerbation of symptomatic arthritis by cigarette smoke in experimental arthritis

  2020cites this paper
• Anti-vimentin antibodies: a unique antibody class associated with therapy-resistant lupus nephritis

  2020cites this paper
• Pre-existing self-reactive IgA antibodies associated with primary graft dysfunction after lung transplantation.

  2020cites this paper
• Mechanosensing dysregulation in the fibroblast: a hallmark of the aging heart.

  2020cites this paper
• Vimentin as a Multifaceted Player and Potential Therapeutic Target in Viral Infections

  2020cites this paper
• Role of vimentin in modulating immune cell apoptosis and inflammatory responses in sepsis

  2019cites this paper
• Vimentin intermediate filament assembly regulates fibroblast invasion in fibrogenic lung injury.

  2019cites this paper
• Citrus Alkaline Extract Delayed the Progression of Pulmonary Fibrosis by Inhibiting p38/NF-κB Signaling Pathway-Induced Cell Apoptosis

  2019cites this paper
• Anti-vimentin antibodies in transplant and disease.

  2019cites this paper
• Emphysema-associated Autoreactive Antibodies Exacerbate Post-Lung Transplant Ischemia-Reperfusion Injury.

  2019cites this paper
• Existing and emerging biomarkers for disease progression in idiopathic pulmonary fibrosis

  2019cites this paper
• IgA Antibodies Directed Against Citrullinated Protein Antigens Are Elevated in Patients with Idiopathic Pulmonary Fibrosis.

  2019cites this paper
• Post-translational modifications of vimentin reflect different pathological processes associated with non-small cell lung cancer and chronic obstructive pulmonary disease

  2019cites this paper
• Shared and distinct mechanisms of fibrosis

  2019cites this paper
• A repertoire of 124 potential autoantigens for autoimmune kidney diseases identified by dermatan sulfate affinity enrichment of kidney tissue proteins

  2019cites this paper
• Systematic review and meta-analysis of clinical significance of autoantibodies for idiopathic pulmonary fibrosis

  2019cites this paper
• Role of Fibroblast Growth Factor 23 and Klotho Crosstalk in Idiopathic Pulmonary Fibrosis.

  2019cites this paper
• Moving target: shifting the focus to pulmonary sarcoidosis as an autoimmune spectrum disorder

  2019influential citation
• Activation of the Absent in Melanoma 2 Inflammasome in Peripheral Blood Mononuclear Cells From Idiopathic Pulmonary Fibrosis Patients Leads to the Release of Pro-Fibrotic Mediators

  2018cites this paper
• The Role of Immune and Inflammatory Cells in Idiopathic Pulmonary Fibrosis

  2018cites this paper
• Recombinant Human Vimentin Binds to P-Selectin and Blocks Neutrophil Capture and Rolling on Platelets and Endothelium

  2018cites this paper
• Biomarkers in idiopathic pulmonary fibrosis.

  2018cites this paper
• Approved and Experimental Therapies for Idiopathic Pulmonary Fibrosis

  2018cites this paper
• Extracellular vimentin modulates human dendritic cell activation

  2018cites this paper
• Vimentin as antigenic target in autoimmunity: A comprehensive review.

  2018cites this paper
• In Situ Humoral Immunity to Vimentin in HLA-DRB1*03+ Patients With Pulmonary Sarcoidosis

  2018cites this paper
• Upregulation of citrullination pathway: From Autoimmune to Idiopathic Lung Fibrosis

  2017cites this paper